Golimumab 50mg/4mL; soln for IV infusion after dilution; preservative- and latex-free. Simponi Aria (golimumab) Injection is a colorless to light yellow solution available in packs of 1 vial.

Accord BioPharma, Inc., the U.S. specialty division of Intas Pharmaceuticals, Ltd. ("Intas Pharmaceuticals"), focused on the ...

their proposed biosimilar to the anti-inflammatory drugs Simponi and Simponi Aria. Review of the applications is expected to by completed in Q4 2025, according to a statement. Simponi and Simponi ...

Alvotechs proposed biosimilar to Simponi and Simponi Aria, or golimumab, which are prescribed to treat a variety of inflammatory conditions. The company noted that these are the first U.S. BLA ...